NYSE$AGL
agilon health inc. · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
agilon health's second quarter results reflected continued momentum, with Medicare Advantage membership increasing 45% year-over-year and total members on the platform growing to over 280,000.
agilon health reported a 70% increase in total revenue to $499 million, driven by a 45% increase in Medicare Advantage membership. However, the company reported a net loss of $299 million, which includes $275 million in non-cash stock-based compensation expenses.
- Total revenue increased 70% from 2020 to $499 million.
- Medicare Advantage membership increased 45% from 2020.
- Same geography membership growth was 17% from 2020.
- Net loss was $299 million, including $275 million in non-cash stock-based compensation expenses.
Headline financials
Revenue & EPS history
agilon health · Revenue · Quarterly
$499M
Revenue by segment
agilon health · $499M total across 2 segments · Q2 2021
- Medical Services Revenue$498M+70.1%99.7%
- Other Operating Revenue$1.28M+16.3%0.3%
Forward guidance
agilon health provided guidance for the third quarter and full year 2021. The company expects ending members to be between 183,000 and 184,000 for Q3 2021 and between 184,000 and 185,000 for the full year. Total revenues are expected to be between $450 million and $453 million for Q3 2021 and between $1.81 billion and $1.82 billion for the full year. Adjusted EBITDA is expected to be a loss between $41 million and $38 million for Q3 2021.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2021
-2.6%
Avg return
Earnings day
-0.0%
Avg return
5 days after
+6.7%
Avg return
30 days after
50%
10 / 20 earnings
Positive
+20.2%
Q4 2025
Best reaction
-36.1%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.2% | +122.0% | +256.9% | |
| Q4 2025 | +20.2% | +13.4% | -20.8% | |
| Q3 2025 | +5.1% | -9.0% | -9.9% | |
| Q1 2025 | -25.6% | -33.4% | -51.6% | |
| Q4 2024 | -7.4% | -17.9% | +23.7% | |
| Q3 2024 | -36.1% | -35.1% | -24.7% | |
| Q2 2024 | -12.7% | -14.6% | -36.8% | |
| Q1 2024 | +7.5% | +7.5% | +40.8% | |
| Q4 2023 | +3.1% | -2.1% | -1.1% | |
| Q3 2023 | -13.1% | -19.0% | -33.1% | |
| Q2 2023 | +0.7% | +3.7% | -7.9% | |
| Q1 2023 | -3.4% | -6.6% | -18.9% | |
| Q4 2022 | +15.4% | +14.8% | +12.0% | |
| Q3 2022 | -12.7% | -7.9% | -8.6% | |
| Q2 2022 | -3.3% | -0.4% | -20.3% | |
| Q1 2022 | -8.6% | -19.4% | +1.3% | |
| Q4 2021 | +10.6% | +2.4% | +31.7% | |
| Q3 2021 | +2.7% | +3.6% | -9.5% | |
| Q2 2021 | -3.8% | -6.3% | -3.4% | |
| Q1 2021 | +6.3% | +4.0% | +14.0% | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro